toripalimab,paclitaxel
junshi biosciences,coherus
['breast', 'toripalimab', 'paclitaxel']
first-line toripalimab plus nab-paclitaxel prolonged pfs for some patients with metastatic triple-negative breast cancer. #asco23 #torchlight 
The content you need, when you need it.